Zancan has been an Associate Professor at the Federal University of Rio de Janeiro (UFRJ), Brazil, since 2007. She received her MSc in 2002 and her PhD in 2005 in biological chemistry at UFRJ Institute of Medical Biochemistry Leopoldo de Meis. In 2008, she established a novel laboratory devoted to the study of signalling in cancer biology, aimed at controlling the development of cancer cells. She had a supervisory role for masters, PhD and post-doctoral fellows, thus contributing to the training of qualified scientific personnel. At the administrative level, she acted as the Head of UFRJ Department of Pharmaceutical Biotechnology (2012–2014). She authored more than 40 scientific articles in peer-reviewed journals. In 2014 and 2015, she spent a sabbatical period at the Université Laval, Québec, Canada, where she was an Invited Professor working at projects related to molecular triggers of diabetes. In 2016, she was nominated as TWAS Young Affiliate and was elected as Co-Chair of TWAS Young Affiliates Network (TYAN).
The research area of Figueiredo is neuroscience focused in understand the pathological neuroimmune modulation that occurs in neurodegenerative diseases, aiming the development of preventive or therapeutics strategies to theses conditions. In one of her first projects as an independent researcher, she used mouse model of sepsis to study the late cognitive impairment associated to this condition. We found that a disrupted hippocampal insulin signalling is linked to memory impairment in sepsis-surviving mice, similarly to what has been described in AD models. Her research group also published important findings related to the alpha-synuclein oligomers, an important toxin associated to Parkinson’s disease. During her career, she has developed a strong and broad background in the study of the fundamental mechanisms that modulate neurodegenerative diseases. She is affiliated member of the Brazilian Academic Science and published more than 50 peer-reviewed papers on topics related to pharmacology and neuroscience. Actually she is proposing a challenging project to elucidate neuroimmune mechanisms involved in Zika Virus infection in the adult central nervous system.
Chaimovich is an Emeritus Professor of Biochemistry, Institute of Chemistry, U. São Paulo (IQUSP), Brazil; Adjunct Coordinator for Special Programs, São Paulo Research Foundation (FAPESP). Former positions: Director, IQUSP; Research Provost, USP; President Brazilian Society of Biochemistry and Molecular Biology; Vice-President of the Brazilian Academy of Sciences, President of the Brazilian Science and Technology Council, CNPq; Vice-President for External Affairs, ICSU; Co-Chair, InterAmerican Network of Academies of Science. His research focuses on fundamental and applied aspects of surfactant aggregates in Chemistry and Biochemistry, including experimental and theoretical analysis of specific ion effects on the properties of surfactant aggregates. Prizes and Distinctions: Brazilian Order for Scientific Merit; TWAS Medal; Commandeur dans l'Ordre des Palmes Académiques, France; Scopus Prize, Elsevier. He is a member of the Academies of Science of Brazil, Chile, Latin America, and Venezuela and a Fellow of the American Association for the Advancement of Science (USA). Contributes regularly to publications in national and international Science Policy.
Barreto completed his Medical Studies and a Master in Public Health at Federal University of Bahia, Brazil. He was awarded a PhD from the University of London. He's a Professor at UFBa and a Senior Investigator at Oswaldo Cruz Foundation. He leads a multidisciplinary research group studying poverty-related infectious diseases, allergy and asthma, the environmental and social determinants of health, health inequalities, and the impact of population-based health and social interventions on health. Recently he set up the Center for Data and Knowledge Integration for Health-CIDACS where is housed the “100 million Brazilians cohort” aimed to evaluate the impact of social programs on health. He was a lead organizer of the Lancet Series on Brazil, published in 2011. He has published over 400 peer-reviewed papers and has supervised 25 successful PhD thesis. He is an elected fellow of the Brazilian Academy of Sciences and of the World Academy of Sciences and an Honorary Professor at the LSHTM
Bouskela is Full Professor and Director of the Clinical Research Unit at the State University of Rio de Janeiro; Director of Technology and Innovation at the Rio de Janeiro State Foundation for Research Support; Member of the Managing Committee for Health at the Ministry of Science, Technology, Innovation and Communication; Full Member of the National Academy of Medicine; Full Member of the Brazilian Academy of Sciences; Full Member of the European Academy of Sciences and Arts; Associate Member of the Académie Nationale de Médicine of France and recipient of the Tiradentes Medal given by the Government of Rio de Janeiro state. She obtained her PhD in 1978 at the Federal University of Rio de Janeiro after spending 3 years at the Mayo Clinic (Rochester, MN) and at University of Washington (Seattle, WA) and her Docent degree in 1992 at the University of Lund, Sweden.
Laboratório de Pesquisas Clínicas e Experimentais em Biologia Vascular – Pavilhão Reitor Haroldo Lisboa da Cunha, térreo – Centro Biomédico – Universidade do Estado do Rio de Janeiro – Rua São Francisco Xavier, 524 – Rio de Janeiro RJ 20550-013 – Brazil